Bríd M Ryan
Affiliation: National Institutes of Health
- Survivin: a new target for anti-cancer therapyBríd M Ryan
Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 4258, USA
Cancer Treat Rev 35:553-62. 2009..The optimum use of survivin antagonists in the treatment of cancer is likely to be in combination with conventional cancer therapies...